UK to Reconsider Use of Alimta
December 21, 2006 - The National Institute for Health and Clinical Excellence (NICE) in the United Kingdom has decided to reconsider the blocking of Alimta, a drug used to treat those who are suffering from mesothelioma, an asbestos-related cancer for which Alimta shows the most promise of any on the market.
Earlier this year, NICE officials […]